High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma

Abstract Background Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the first rate-limiting enzyme of the hexosamine biosynthesis pathway (HBP), which plays a pivotal role in the progression of pancreatic ductal adenocarcinoma (PDAC). Therefore, we investigated the prognostic significance o...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yitao Gong, Yunzhen Qian, Guopei Luo, Yu Liu, Ruijie Wang, Shengming Deng, He Cheng, Kaizhou Jin, Quanxing Ni, Xianjun Yu, Weiding Wu, Chen Liu
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2021-01-01
סדרה:	World Journal of Surgical Oncology
נושאים:	Glutamine-fructose-6-phosphate transaminase 1 Hexosamine biosynthesis pathway (HBP) Survival Prognosis
גישה מקוונת:	https://doi.org/10.1186/s12957-021-02147-z
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!